Why Do I Feel Dizzy When I Stand Up? A Guide for Patients and Their Physicians

For the Patient You get up from the couch, and suddenly the room spins. Your vision darkens at the edges. You grab the nearest wall and wait for it to pass. If this sounds familiar, you may be experiencing orthostatic hypotension (OAH) — a condition far more common than most people realize, and one with a clear explanation. What Is It? Orthostatic hypotension means your blood pressure drops significantly the moment you stand up. Medically, it is defined as a fall of at least 20 mmHg in your top blood pressure number, or 10 mmHg in your bottom number, within three minutes of standing. That brief drop reduces blood flow to your brain — causing dizziness, blurred vision, weakness, or that unsettling "going to faint" feeling. What Should Normally Happen? When you stand, gravity pulls blood downward into your legs and abdomen. Your heart briefly receives less blood and your pressure dips. Normally, sensors in your arteries detect this instantly and signal your brain to speed up your heart and tighten your blood vessels — restoring pressure within seconds. You feel nothing. In OAH, that rapid recovery fails. Why Does It Happen to You? There is rarely a single cause. Common contributors include: Getting older — arteries stiffen, the sensors that detect pressure changes slow down, and the heart becomes less adaptable. OAH affects fewer than 5% of people in their late 40s, rising to over 25% of those aged 85 and older. Medications — blood pressure drugs, diuretics, antidepressants, and antipsychotics can all lower pressure or blunt your body's reflexes, especially when combined. Dehydration — even mild fluid loss reduces the blood volume your heart needs to maintain pressure on standing. Nervous system conditions — Parkinson's disease, diabetic neuropathy, and similar disorders damage the nerve signals that tell blood vessels to tighten when you rise. Heart conditions — heart failure and arrhythmias limit how effectively the heart responds to the demand of standing upright. What You Should Know OAH is not simply aging. It is a recognized, treatable condition — yet many people suffer for years because symptoms are dismissed as tiredness or old age. Left unmanaged, repeated episodes increase your risk of falls, fractures, and cognitive decline. The first step is bringing your symptoms to your doctor's attention and asking directly: "Could this be orthostatic hypotension?" For the Physician Orthostatic hypotension is estimated to affect 15–25% of community-dwelling older adults and over 30% of those in long-term care settings — yet it remains persistently underdiagnosed in routine clinical practice. Symptoms are frequently attributed to aging, fatigue, or anxiety rather than recognized as a specific, measurable, and treatable hemodynamic disturbance. Pathophysiology in Brief On standing, approximately 500–1000 mL of blood shifts gravitationally to the lower extremities and splanchnic circulation, transiently reducing venous return, stroke volume, and cardiac output. The healthy response — baroreceptor-mediated sympathetic activation, increased heart rate and peripheral vascular resistance — restores blood pressure within seconds. OAH reflects a failure of this compensatory loop. Key mechanisms include impaired baroreceptor sensitivity (accelerated by arterial stiffness and atherosclerosis), autonomic dysfunction (neurogenic causes), reduced intravascular volume, medication-induced vasodilation or autonomic blunting, and diminished peripheral vascular responsiveness in aged or diseased smooth muscle. Clinical Vigilance Screening is warranted in any patient over 60, or younger patients presenting with unexplained falls, syncope, fatigue, or cognitive change. Orthostatic vital signs — supine after 5 minutes of rest, then at 1 and 3 minutes of standing — remain the essential and often neglected diagnostic step. Note that delayed OAH (onset beyond 3 minutes) and neurogenic OAH (blunted compensatory tachycardia, ΔHR/ΔSBP ratio <0.5 bpm/mmHg) require specific awareness to avoid underdetection. Polypharmacy review is equally critical. Antihypertensives, alpha-blockers, tricyclic antidepressants, and dopaminergic agents are frequent contributors — and their cumulative effect often matters more than any single agent. Pharmacological Support of Peripheral Vascular Resistance When non-pharmacological measures — hydration, dietary sodium, compression garments, and postural training — prove insufficient, targeted medications that enhance peripheral vascular resistance are the next step. Three agents are the current clinical standard: Midodrine (2.5–10 mg orally, three times daily) is a selective alpha-1 adrenergic agonist. It acts directly on peripheral arterioles and venous capacitance vessels, increasing vascular resistance and reducing venous pooling on standing. Onset is rapid (30–60 minutes). Avoid dosing within 4–5 hours of bedtime to minimize supine hypertension. Common side effects include piloerection, scalp tingling, and urinary retention — the last requiring caution in men with prostatic hypertrophy. Fludrocortisone (0.1–0.3 mg orally, once daily) is a synthetic mineralocorticoid that expands plasma volume through sodium and water retention, secondarily improving vascular filling pressure and peripheral resistance. It is particularly useful in volume-depleted patients. Monitor closely for hypokalemia, fluid overload, and supine hypertension with long-term use. Avoid in heart failure or poorly controlled hypertension. Droxidopa (100–600 mg orally, three times daily) is a norepinephrine prodrug indicated specifically for neurogenic OAH — including Parkinson's disease, multiple system atrophy, and pure autonomic failure. Converted peripherally to norepinephrine, it restores sympathetic vascular tone at the postganglionic level. FDA-approved for this indication, it is especially valuable when fatigue is a prominent symptom or when midodrine is not tolerated. Titrate gradually; monitor for supine hypertension and headache. A practical note on all three agents: supine hypertension is a shared risk. Instruct patients to take doses on a schedule tied to activity (not bedtime), sleep with the head of the bed elevated 20–30 cm, and monitor blood pressure in both lying and standing positions at follow-up. A Shared Responsibility Effective management of OAH begins with recognition. For patients, that means feeling heard and informed. For clinicians, it means looking beyond the blood pressure number to the person experiencing falls, withdrawing from daily life, and quietly losing independence. Together — with individualized non-pharmacological strategies as the foundation and targeted pharmacotherapy when needed — outcomes can be meaningfully improved. You can learn more by reading our e-book or listening to our audiobook